{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:29:15Z","timestamp":1789086555095,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100021726","name":"Direktorat Riset and Pengembangan, Universitas Indonesia","doi-asserted-by":"publisher","award":["NKB-319\/UN2.RST\/HKP.05.00\/2023"],"award-info":[{"award-number":["NKB-319\/UN2.RST\/HKP.05.00\/2023"]}],"id":[{"id":"10.13039\/501100021726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jdiacomp.2025.109202","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:38:16Z","timestamp":1760999896000},"page":"109202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum analysis of type 2 diabetes mellitus patients with low, moderate, and high risk of diabetic kidney disease using LC-MS metabolomics approach"],"prefix":"10.1016","volume":"40","author":[{"given":"Salwa Dilfari","family":"Pohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani","family":"Sauriasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baitha Palanggatan","family":"Maggadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taufiq Indra","family":"Rukmana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Mahdiyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathia","family":"Yusrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri","family":"Hayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Johari","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Salleh","family":"Rofiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teh Lay","family":"Kek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Zaki","family":"Salleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109202_bb0005","doi-asserted-by":"crossref","unstructured":"IDF. International Diabetes Federation. 2021. doi:https:\/\/doi.org\/10.1016\/j.diabres.2013.10.013.","DOI":"10.1016\/j.diabres.2013.10.013"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0010","series-title":"Classification of diabetes mellitus","volume":"21","author":"WHO","year":"2019"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0015","series-title":"Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021","author":"PERKENI","year":"2021"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0020","first-page":"60","article-title":"Prevalence of diabetic nephropathy among type 2 diabetic patients in some of the Arab countries","volume":"11","author":"Aldukhayel","year":"2017","journal-title":"Int J Health Sci"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.maturitas.2011.11.009","article-title":"Chronic kidney disease and diabetes","volume":"71","author":"Pyram","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.mpmed.2022.08.002","article-title":"Diabetic kidney disease key points","volume":"50","author":"Thomas","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0035","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","author":"KDIGO","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-020518-114605","article-title":"Biomarkers of acute and chronic kidney disease","author":"Zhang","year":"2019","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2016.05.018","article-title":"Changes in serum metabolites with the stage of chronic kidney disease: comparison of diabetes and non-diabetes","volume":"459","author":"Lee","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0050","first-page":"1","article-title":"Comparison of nonalbuminuric and albuminuric diabetic kidney disease among patients with type 2 diabetes: a systematic review and meta-analysis","volume":"13","author":"Shi","year":"2022"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/acsmeasuresciau.1c00007","article-title":"A workflow to perform targeted metabolomics at the untargeted scale on a triple quadrupole mass spectrometer","volume":"1","author":"Schwaiger-Haber","year":"2021","journal-title":"ACS Meas Sci Au"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0060","article-title":"Metabolomic approaches to investigate the effect of metformin: an overview","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0065","doi-asserted-by":"crossref","unstructured":"Zhang H, Zuo J jing, Dong S si, Lan Y, Wu C wei, Mao G yun, et al. Identification of potential serum metabolic biomarkers of diabetic kidney disease: a widely targeted metabolomics study. J Diabetes Res 2020;2020. doi:https:\/\/doi.org\/10.1155\/2020\/3049098.","DOI":"10.1155\/2020\/3049098"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.33176\/AACB-19-00023","article-title":"Quadrupole time-of-flight mass spectrometry: a paradigm shift in toxicology screening applications","volume":"40","author":"Allen","year":"2019","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0075","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2810251","article-title":"Serum metabolomic profile in hypoxia-induced pulmonary hypertension mice after C75 treatment","volume":"28","author":"Chen","year":"2023","journal-title":"Front Biosci - Landmark"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/14791641211058856","article-title":"Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: a review of the literature","volume":"18","author":"Thipsawat","year":"2021","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0085","doi-asserted-by":"crossref","DOI":"10.21037\/jlpm.2018.08.01","article-title":"Serum creatinine: advantages and pitfalls","volume":"3","author":"Bargnoux","year":"2018","journal-title":"J Lab Precis Med"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0090","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0095","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jdiacomp.2018.07.004","article-title":"The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges","volume":"32","author":"Gan","year":"2018","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0100","first-page":"82","article-title":"Use of metabolomics in improving assessment of dietary intake","volume":"64","author":"Bhupathiraju","year":"2019"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0105","doi-asserted-by":"crossref","unstructured":"Kujala UM, M\u00e4kinen V, Heinonen I, Soininen P. Long-term Leisure-time Physical Activity and 2012;35:340\u20138. doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.105551.","DOI":"10.1161\/CIRCULATIONAHA.112.105551"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0110","doi-asserted-by":"crossref","unstructured":"W\u00fcrtz P, M\u00e4kinen V, Soininen P, Kangas AJ, Tukiainen T, Kettunen J, et al. Metabolic signatures of insulin resistance in 7,098 young adults n.d. doi:https:\/\/doi.org\/10.2337\/db11-1355, Diabetes.","DOI":"10.2337\/db11-1355"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0115","first-page":"1","article-title":"Plasma levels of amino acids related to urea cycle and risk of type 2 diabetes mellitus in Chinese adults","volume":"10","author":"Cao","year":"2019"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0120","first-page":"698","article-title":"Plasma and urinary concentrations of arachidonic acid-derived eicosanoids are associated with diabetic kidney disease","volume":"20","author":"Mota-Zamorano","year":"2021","journal-title":"EXCLI J"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s43088-022-00257-5","article-title":"Exploring key molecular signatures of immune responses and pathways associated with tuberculosis in comorbid diabetes mellitus: a systems biology approach","author":"Selvan","year":"2022","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4239\/wjd.v13.i4.308","article-title":"Gut microbiota and diabetic kidney diseases: pathogenesis and therapeutic perspectives","volume":"13","author":"Lin","year":"2022","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s43088-023-00384-7","article-title":"Evaluating the role of cytokinesis - block micronucleus assay as a biomarker for oxidative stress - inducing DNA damage in type 2 diabetes mellitus patients","author":"Vishakh","year":"2023","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms23084244","article-title":"Implications of sphingolipid metabolites in kidney diseases","volume":"23","author":"Mallela","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22041816","article-title":"Convergence: lactosylceramide-centric signaling pathways induce inflammation, oxidative stress, and other phenotypic outcomes","volume":"22","author":"Chatterjee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/jcm12237349","article-title":"Pathomechanisms of diabetic kidney disease","volume":"12","author":"Sinha","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0155","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/248135","article-title":"Sphingolipid and ceramide homeostasis: potential therapeutic targets","volume":"2012","author":"Young","year":"2012","journal-title":"Biochem Res Int"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabet.2020.03.003","article-title":"Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease","volume":"47","author":"Mantovani","year":"2021","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107734","article-title":"Role of ceramides in the pathogenesis of diabetes mellitus and its complications","volume":"35","author":"Mandal","year":"2021","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0170","first-page":"1","article-title":"Metabolic homeostasis of amino acids and diabetic kidney disease","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/ars.2016.6664","article-title":"Diabetes and kidney disease: role of oxidative stress","volume":"25","author":"Jha","year":"2016","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22112015","article-title":"Taxon- and site-specific melatonin catabolism","volume":"22","author":"Hardeland","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0185","doi-asserted-by":"crossref","first-page":"18886","DOI":"10.3390\/molecules201018886","article-title":"Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism","volume":"20","author":"Tan","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0190","article-title":"Inflammation and oxidative stress in chronic kidney disease\u2014potential therapeutic role of minerals, vitamins and plant-derived metabolites","volume":"21","author":"Rapa","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cells12060838","article-title":"Melatonin treatment in kidney diseases","volume":"12","author":"Markowska","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101068","article-title":"Emerging roles of lysophospholipids in health and disease","volume":"80","author":"Tan","year":"2020","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12035-014-8662-4","article-title":"Role of cytosolic phospholipase A2in oxidative and inflammatory signaling pathways in different cell types in the central nervous system","volume":"50","author":"Sun","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21124501","article-title":"An updated review of pro-and anti-inflammatory properties of plasma lysophosphatidylcholines in the vascular system","volume":"21","author":"Knuplez","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0215","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1517\/14656566.2015.1114098","article-title":"Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus","volume":"16","author":"Triplitt","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0220","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.23876\/j.krcp.21.251","article-title":"Exploring molecular targets in diabetic kidney disease","volume":"41","author":"Maruno","year":"2022","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0230","first-page":"1","article-title":"Arachidonic acid metabolism and kidney inflammation","volume":"20","author":"Wang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mco2.363","article-title":"Arachidonic acid metabolism in health and disease","volume":"4","author":"Zhang","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0240","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1152\/ajprenal.90613.2008","article-title":"Glomerular 20-HETE, EETs, and TGF-\u03b21 in diabetic nephropathy","volume":"296","author":"Luo","year":"2009","journal-title":"Am J Physiol-Ren Physiol"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0245","first-page":"1","article-title":"Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy","author":"Stangenberg","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0250","first-page":"1","article-title":"L-arginine in diabetes: clinical and preclinical evidence","volume":"22","author":"Forzano","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0255","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tem.2019.10.001","article-title":"Role of nitric oxide in insulin secretion and glucose metabolism","volume":"31","author":"Bahadoran","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0260","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ncpneph0143","article-title":"Arginine, arginine analogs and nitric oxide production in chronic kidney disease","volume":"2","author":"Baylis","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-35653-z","article-title":"A closer association between blood urea nitrogen and the probability of diabetic retinopathy in patients with shorter type 2 diabetes duration","volume":"13","author":"Zhong","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/ajlm.v10i1.1398","article-title":"Relationship between amino acid ratios and decline in estimated glomerular filtration rate in diabetic and non-diabetic patients in South Africa","volume":"10","author":"Mbhele","year":"2021","journal-title":"Afr J Lab Med"},{"key":"10.1016\/j.jdiacomp.2025.109202_bb0275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nupar.2024.10.008","volume":"39","author":"Ahmed","year":"2025","journal-title":"Nutr Clin M\u00e9tabolisme"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725002557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725002557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T12:01:12Z","timestamp":1766232072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725002557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1056872725002557"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109202","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum analysis of type 2 diabetes mellitus patients with low, moderate, and high risk of diabetic kidney disease using LC-MS metabolomics approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025","name":"copyright","label":"Copyright"}],"article-number":"109202"}}